Drug recall · June 15, 2016
CEFTRIAXONE for Injection USP recall
Why: CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
CEFTRIAXONE for Injection USP, 250mg/vial, Rx only, MFG: LUPIN LIMITED INDIA, Packaged by Aidarex Pharmaceuticals, NDC 53217-0117-01
- Lots / codes
Lot#: 47312-1, Exp 01/2018
- Quantity
- 10
- Company
- Aidarex Pharmaceuticals LLC, Corona, CA
- Distribution
- IN, GA
- Initiated
- June 1, 2016 · Voluntary: Firm initiated
- Classified
- June 7, 2016
- Reported
- June 15, 2016
- Ended
- October 14, 2016
- How notified
- FAX
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ceftriaxone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.